glp-1 compounding news november 2025 Patients struggle as compounded access rapidly shrinks FDA issued 25 warning letters

Cell Rep Med 4(11) Dankner R, Murad H, Agay N, Olmer L, Freedman LS (2024) Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk in patients with type 2 diabetes

Any weight loss can reduce the number of calories your body burns at rest, making it easier to regain weight

A Dual-Action Treatment Tirzepatide is known as a dual agonist because it works on two hormone pathways in the body: GLP-1 and GIP

In December 2007, I was privileged to see a recently released population with Russ Mittermeier, the then-president of Conservation International (now executive vice chair), and witness the success of the conservation operation, with several adult birds occupying natural nest cavities as well as nest boxes

The natural epidermal turnover cycle

Insurance coverage and patient assistance programs may help reduce out-of-pocket costs for eligible patients